来自埃及考古遗址的抗菌代谢物的生产和表征
Aalaa A Youssef1, Bassma H Elwakil2, Doaa A Ghareeb3,4,5
1Botany and Microbiology Department, Faculty of Science, Alexandria University, Alexandria, 21500, Egypt. Alaa.Atef_PG@alexu.edu.eg.
Scientific reports
|June 27, 2025
概括
从埃及考古遗址发现的细菌Xenorhabdus nematophila中发现了新的抗菌化合物. 优化生产和纳米配方Xenortide证明了增强的抗菌和抗癌特性,提供了一个有前途的新治疗剂.
科学领域:
- 微生物学 微生物学
- 生物化学 生物化学
- 纳米技术纳米技术
背景情况:
- 抗微生物耐药性的出现需要发现新的治疗剂.
- 克塞诺哈布杜斯 (Xenorhabdus spp.) 的其他种类. 是已知的生物活性化合物的生产者,具有潜在的抗微生物活性.
研究的目的:
- 从埃及考古遗址中分离和识别具有抗微生物特性的细菌.
- 描述和优化生产一种新型抗菌化合物,Xenortide的生产.
- 为了合成和评估纳米-xenortide 抗菌和抗癌疗效.
主要方法:
- 细菌菌株的隔离和鉴定.
- 使用LC-MS和NMR识别生物活性化合物xenortide.
- 使用中央复合统计设计优化异二氧化物生产.
- 通过球磨法合成和表征纳米-xenortide.
主要成果:
- Xenorhabdus nematophila被确定为一种强大的抗菌活性来源.
- 确定了 xenortide 生产的最佳发酵条件.
- 与原生化合物相比,纳米-色诺提德表现出增强的抗菌疗效.
- 纳米-xenortide 证明了作为一种抗结肠直肠癌药物的有希望的安全性和有效性.
结论:
- 由Xenorhabdus nematophila产生的Xenortide是一种具有显著治疗潜力的新型生物活性化合物.
- 纳米-xenortide代表了一种先进的配方,具有改善的抗菌和抗癌特性.
- 这项研究突出了微生物衍生化合物来自独特环境的药物发现潜力.
相关概念视频
Biological Methods for Microbial Control
214
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
214
Antimicrobial Effectiveness
175
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
175
Antibiotic Selection
55.4K
Overview
55.4K


